Provexis
AIM:PXS
£ 0,01
£0,00 (0,00%)
0,01 £
£0,00 (0,00%)
End-of-day quote: 10/13/2025

Provexis Stock Value

Analysts currently give Provexis a rating of sf_Data Unavailable.
-

Provexis Company Info

EPS Growth 5Y
0,00%
Market Cap
£0,01 B
Long-Term Debt
£0,00 B
Quarterly earnings
09/10/2026 (E)
Dividend
£0,00
Dividend Yield
0,00%
Founded
1999
Industry
Website
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Provexis’s Price Target has risen from £0,05 to £0,05 - a 0,00% increase.

Top growth stocks in the health care sector (5Y.)

What does Provexis do?

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Business Segments The company operates several distinct business segments focusing on product development, ingredient sales, and collaborative agreements. The primary segments reported include: Fruitflow II SD Ingredient This segment represents a strategic advancement in the company's portfolio, which endeavors to provide a standardized ingredient ai...
×